Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ed598b8-b91f-41ab-b592-bc798ae3e1c8 Date 7/20/2016 Company Name Akili Interactive Mailing Address 501 Boylston Street Boston, MA 02116 USA Company Description Transforming healthcare with clinically-validated digital medicine. Website http://www.akiliinteractive.com Transaction Type Venture Equity Transaction Amount $11,900,000 Transaction Round Series B Proceeds Purposes Akili will use the funds to support and expand clinical development of its … Continue reading “Akili Interactive Receives $11,900,000 Series B Funding”
Category: Boston
Verisk Analytics Acquires Greentech Media for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=747f3d26-8a11-4289-8108-2949af17ec05 Date 7/20/2016 Company Name Greentech Media Mailing Address 2 liberty Square Boston, MA 02109 USA Company Description Greentech Media was founded in January 2007 with the vision of creating a fully integrated online-media company comprised of cutting-edge news, in-depth technical research & analysis, and focused industry events. Research and analysis is … Continue reading “Verisk Analytics Acquires Greentech Media for Undisclosed Sum”
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting
Zafgen’s prospects have been unclear ever since two patients died in a Phase 3 trial of its lead drug candidate, beloranib, a potential treatment for obesity in patients with a rare disease known as Prader-Willi Syndrome. The question looming over the Boston company: Could Zafgen win approval of the drug despite its apparent safety risks, … Continue reading “Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting”
Rize Emerges With 3D Printer That Makes Easily Refined Parts
A startup’s struggle to stand out in a crowded industry can sometimes get a lift from a distinguishing product feature or the decision to focus on solving a specific problem. That theory will be put to the test with Rize. Today the Boston-area 3D printing startup unveiled what it’s been working on for more than … Continue reading “Rize Emerges With 3D Printer That Makes Easily Refined Parts”
Is the Future of Cybersecurity in M&A?
Last month Symantec announced its plans to buy Blue Coat for $4.7 billion. Has the consolidation—and creation of this enterprise security giant—put immense pressure on other industry players? In an ideal world, and from the perspective of a venture investor, this would absolutely be the case. In 2015, Cybersecurity startups saw 332 funding deals with … Continue reading “Is the Future of Cybersecurity in M&A?”
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses
The field of cancer immunotherapy is so crowded and competitive these days that many companies are trying to stand by touting a next-generation approach. The latest company to do so is Oncorus, a Cambridge, MA-based startup that this morning closed a $57 million from a large group of investors. Oncorus was incubated within MPM Capital last year … Continue reading “Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses”
Forum Exodus Continues as CSO Koenig Heads to Quartet
Forum Pharmaceuticals shut down a few weeks ago, and now one of its top executives has resurfaced at a new company. Gerhard Koenig, Forum’s former chief scientific officer and head of research, has been named the CEO of Cambridge, MA-based Quartet Medicine, a startup developing pain drugs. Merck, in January, grabbed an exclusive option to … Continue reading “Forum Exodus Continues as CSO Koenig Heads to Quartet”
Cyber Consolidation: Carbon Black Buys Confer in Endpoint Security
In what could be another sign of a shakeout in the cybersecurity industry, Carbon Black says today it has acquired fellow Boston-area security firm Confer Technologies. The deal has closed, but financial terms weren’t given. Both companies focus on endpoint security—software that helps organizations detect and respond to threats against computers, devices, and servers. Waltham, … Continue reading “Cyber Consolidation: Carbon Black Buys Confer in Endpoint Security”
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner”
It’s getting harder and harder to stand out in the increasingly crowded cancer immunotherapy field. But with a wide-ranging alliance being announced this morning, three-year-old Jounce Therapeutics has been able to make its mark. The Cambridge, MA-based company has inked a deal to work with Summit, NJ-based Celgene (NASDAQ: [[ticker:CELG]]) on a group of experimental … Continue reading “With Celgene Deal, Jounce Lands $261M And a “Trusting Partner””
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs
Former Epizyme CEO Robert Gould is back with a new startup. A year after stepping down as the CEO of Cambridge, MA-based Epizyme, Gould has re-emerged to lead another Cambridge company, Fulcrum Therapeutics, which has secured a massive $55 million Series A round from Third Rock Ventures. There are some similarities between Gould’s old job … Continue reading “Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs”
Neurovance Receives $5,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c6ee3cf6-e031-4d9a-9b2a-45da9e9b9e12 Date 7/19/2016 Company Name Neurovance Mailing Address 43 Thorndike Street Cambridge, MA 02141 USA Company Description Neurovance is a clinical stage neuroscience-focused company. Following development of centanafadine SR (formerly EB-1020 SR) for adult ADHD, Neurovance will develop centanafadine SR for adolescent and pediatric ADHD. Website http://www.neurovance.com Transaction Type Debt Transaction Amount … Continue reading “Neurovance Receives $5,000,000 New Financing”
Cadenza Innovation Secures $5,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d0eee8d5-6094-4a79-921d-48d79b21329a Date 7/19/2016 Company Name Cadenza Innovation Mailing Address 3 Morse Road Oxford, CT 06478 USA Company Description We recognize that every member of the Cadenza Innovation ensemble has a unique perspective and we want to hear it. Our goal is to combine creativity with deep industry knowledge to drive innovative solutions … Continue reading “Cadenza Innovation Secures $5,000,000 Series A Financing”
Carbon Black Acquires Confer for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3265b852-c398-4126-9e05-29addcaeaf21 Date 7/19/2016 Company Name Confer Mailing Address 344 Boylston Street Boston, MA 02116 USA Company Description Confer provides coordinated attack detection, prevention and incident response across endpoints, servers and cloud workloads. Website http://www.confer.net Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms The company’s press release said the … Continue reading “Carbon Black Acquires Confer for Undisclosed Sum”
Boston Tech Watch: Noncompetes, Funding Blitz, Battery Tech & More
As the weather heats up in the Boston area today, stay cool with the latest local tech headlines: —The Massachusetts Senate passed a bill that puts stronger limits on noncompete agreements than a related bill passed earlier by the House. The Senate version caps noncompetes at three months and requires employers to pay the departed … Continue reading “Boston Tech Watch: Noncompetes, Funding Blitz, Battery Tech & More”
The Pan-Cancer Screen: Still Early for Prime Time
Imagine you could go to your doctor once a year for a blood test that would detect nearly every common type of cancer at an early stage. If you had a positive result, some further testing could pinpoint the cancer so you could have it treated before it spread. I would be ecstatic to have … Continue reading “The Pan-Cancer Screen: Still Early for Prime Time”
Ziopharm Discloses Patient Death in Brain Cancer Trial, Shares Fall
A patient died after receiving Ziopharm Oncology’s experimental treatment for an aggressive form of brain cancer, but the Boston-based biotech company describes the death as “an isolated case” and plans to continue the study. Nonetheless, the news has spooked investors and Ziopharm’s (NASDAQ: [[ticker:ZIOP]]) stock price slipped more than 13 percent to $4.89 this morning. … Continue reading “Ziopharm Discloses Patient Death in Brain Cancer Trial, Shares Fall”
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News
The week started on a reflective note. Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. And then the news flowed, from a fast reprieve for Juno Therapeutics to no mercy for Elizabeth Holmes. There were other goodbyes: … Continue reading “Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News”
‘Megadeals’ Dominate Q2 as VCs Invest $15.3B, and Top 10 Deals
Showing little concern for stock-market volatility or worries over the Brexit, venture capital firms pumped $15.3 billion into 961 deals across the United States during the three months that ended June 30, according to the MoneyTree Report on venture capital activity. It was the 10th consecutive quarter that venture firms put at least $10 billion … Continue reading “‘Megadeals’ Dominate Q2 as VCs Invest $15.3B, and Top 10 Deals”
Deciphera Pharmaceuticals Receives $75,604,034 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=93aa15dc-4d7f-4579-9c7e-adfce78ea4db Date 7/15/2016 Company Name Deciphera Pharmaceuticals Mailing Address 1601 Trapelo Road Waltham, MA 02451 USA Company Description Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials … Continue reading “Deciphera Pharmaceuticals Receives $75,604,034 New Round”
Quilt Garners $3,250,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b750212-d7c9-485a-abcd-e16cd6fd13f7 Date 7/15/2016 Company Name Quilt Mailing Address Undisclosed Boston, MA 02110 USA Company Description Quilt is for people who live online, value what they have, and expect more from their insurance. We promise: we’ll never make you read pages of legalese or hound you with calls from salesy agents. Website http://www.getquilt.com … Continue reading “Quilt Garners $3,250,000 Seed Funding”
Altiostar Secures $10,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a21478da-7c81-47c6-9eb4-e8f5de4730a4 Date 7/15/2016 Company Name Altiostar Mailing Address 200 Ames Pond Drive Tewksbury, MA 01876 USA Company Description Altiostar is the mobile broadband industry’s first provider of Virtual RAN (vRAN) with Ethernet front haul, for software-intensive LTE eNodeB. Our unique solution is designed to improve quality of experience, enhance spectral efficiency and … Continue reading “Altiostar Secures $10,000,000 New Funding Round”
Sarepta Stock Down as FDA Seeks More Data from Rival Duchenne Drug
Sarepta Therapeutics still awaits an FDA decision on its Duchenne muscular dystrophy drug. But the agency’s conclusion that another company working on a treatment for the muscle-wasting disease needs to submit more information is leading some observers to believe that approval chances for Cambridge, MA-based Sarepta’s drug are slim. The FDA has informed Santhera Pharmaceuticals … Continue reading “Sarepta Stock Down as FDA Seeks More Data from Rival Duchenne Drug”
CyberGRX Gets $9M to Manage Security Risks From Business Partners
An interesting cybersecurity startup emerged from stealth mode in Denver today. CyberGRX, which develops cyber risk management software, said it has closed $9 million in Series A funding, led by Allegis Capital. The company’s other investors include a mix of venture firms such as Blackstone, TenEleven Ventures, Rally Ventures, GV, and MassMutual Ventures, and security … Continue reading “CyberGRX Gets $9M to Manage Security Risks From Business Partners”
Why Entrepreneurs Should Care About Inequality and Divisiveness
The horrific news of recent weeks has amplified America’s long-simmering tensions and many divisions, and cast a new and disturbing light on the nature of social and economic inequality in this economy. The shootings that targeted police officers at a peaceful protest in Dallas, which followed the officer-involved shooting deaths of Philando Castile near Minneapolis … Continue reading “Why Entrepreneurs Should Care About Inequality and Divisiveness”
Augmenix Receives $6,000,000 Series E Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e5da211-298c-4986-b05a-25f89c2a8ad9 Date 7/14/2016 Company Name Augmenix Mailing Address 204 2nd Avenue Lower Level Waltham, MA 02451 USA Company Description Augmenix’s hydrogel technology improves outcomes in prostate radiation oncology and surgery. Learn more about the SpaceOAR system. Website http://www.augmenix.com Transaction Type Venture Equity Transaction Amount $6,000,000 Transaction Round Series E Proceeds Purposes This infusion … Continue reading “Augmenix Receives $6,000,000 Series E Financing”
Fontinalis Closes New $100M Fund Supporting Mobility Startups
When Fontinalis Partners launched its first venture fund in 2009 to invest in early-stage mobility startups, many in the VC world didn’t quite know what mobility was. Defined by Fontinalis as “the efficient movement of goods, people, and services across all modes of transportation,” mobility has come to encompass ridesharing services like Lyft and Uber, … Continue reading “Fontinalis Closes New $100M Fund Supporting Mobility Startups”
No Profits, No Problem: Imprivata Bought by Private Equity for $544M
One of the stalwarts of Boston’s technology scene is going private again. Lexington, MA-based Imprivata, a developer of health IT security software, is getting bought by a private equity firm two years after going public. Imprivata has agreed to be acquired by Thoma Bravo for about $544 million. The price per share ($19.25) represents a … Continue reading “No Profits, No Problem: Imprivata Bought by Private Equity for $544M”
True Fit Nabs $25M to Make Online Shopping More Personal
Shopping is getting more personal, as retailers and brands try to use data analytics to deliver curated and targeted product recommendations to consumers online—and ideally boost sales. The latest example is True Fit, a Woburn, MA-based software company that has amassed millions of data points on the fit and style of shoes and clothing products, … Continue reading “True Fit Nabs $25M to Make Online Shopping More Personal”
Decibel Therapeutics Hires Biogen Exec Steven Holtzman as New CEO
Decibel Therapeutics has hired Steven Holtzman, a former Biogen executive, as its president and chief executive officer. Holtzman has had a long career in executive roles, including as CEO and board director at Infinity Pharmaceuticals and the chief business officer of Millennium Pharmaceuticals. Holtzman most recently came from the role of executive vice president for … Continue reading “Decibel Therapeutics Hires Biogen Exec Steven Holtzman as New CEO”
How Cyber Visibility Protects Against the Abnormal & the Immoral
Another day, another breach. For many Bostonians, the “privacy incident” recently disclosed by Massachusetts General Hospital (MGH)—which reportedly involved the personal information of 4,300 dental patients stored by a software vendor—hit close to home in many ways, as most of us have at one time or another been to MGH for ourselves or a loved … Continue reading “How Cyber Visibility Protects Against the Abnormal & the Immoral”
Can Innovation Save Us?
During a summer that’s been marred by political upheaval and horrific violence inside and outside the U.S., it’s natural for startup entrepreneurs and others immersed in the technology world—including us journalists—to wonder about the role of innovation in solving social problems. In the wake of the murder of five police officers in Dallas, which followed … Continue reading “Can Innovation Save Us?”
TransMedics Secures $12,500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed3f7a2b-dccf-48d8-8f8d-11605ba2d30f Date 7/13/2016 Company Name TransMedics Mailing Address 200 Minuteman Road Andover, MA 01810 USA Company Description TransMedics has developed a revolutionary new system that enables living organ transplants. Website http://www.transmedics.com Transaction Type Venture Equity Transaction Amount $12,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 20 investors participated in … Continue reading “TransMedics Secures $12,500,000 New Funding”
True Fit Garners $25,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3abd5de0-b1d9-4191-a685-b0eb1046d4f5 Date 7/13/2016 Company Name True Fit Mailing Address 800 West Cummings Park Woburn, MA 01801 USA Company Description My True FitSM is an e-commerce site powered by proprietary True FitSM software that deftly matches individuals to the items of clothing and shoes that best fit their personal style and unique body … Continue reading “True Fit Garners $25,000,000 Series B Round”
7AC Technologies Obtains $6,249,998 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e9f642ae-902d-43d6-892b-c87a014b117e Date 7/13/2016 Company Name 7AC Technologies Mailing Address 100 Cummings Center Beverly, MA 01915 USA Company Description 7AC Technologies energy-saving ultra-efficiency air conditioning systems. Website http://www.7actech.com Transaction Type Venture Equity Transaction Amount $6,249,998 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount … Continue reading “7AC Technologies Obtains $6,249,998 New Funding”
From Drones to Sharing Economy, Don’t Disrupt the Disruptors
Napa Valley met the Silicon Valley at the recent Xconomy Retreat on Technology, Jobs, and Growth (aka the Napa Summit). Experts in cutting-edge technology huddled with business leaders and investors in the California wine country to explore what’s on, and just over, the technological horizon. Over the course of the two-day event, drones and the … Continue reading “From Drones to Sharing Economy, Don’t Disrupt the Disruptors”
Caveats But No “Quicksand” In Sage’s Positive Postpartum Trial Data
[Updated 7/12/16, 4:07 p.m., with final share price. See below.] Sage Therapeutics has avoided the “great quicksand of drug development” for now. That was Sage CEO Jeff Jonas’s description of depression a couple months ago in a conversation with Xconomy. Today, Sage (NASDAQ: [[ticker:SAGE]]) is reporting positive Phase 2 data in postpartum depression, an often … Continue reading “Caveats But No “Quicksand” In Sage’s Positive Postpartum Trial Data”
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017
While the Obama administration wants to dedicate a tiny sliver of the federal budget to microbiome research, a growing number of startups—often with the backing of international corporations—are racing to turn microbiome research into health products. The Cambridge, MA-based firm Evelo Biosciences wants to harness live bacteria as cancer and immune-disease treatments. Evelo, which launched … Continue reading “With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017”
With Positive Postpartum Results, Sage Ponders More Mood Disorders
[Corrected 11:53 a.m. See below.] Sage Therapeutics’ new clinical trial results for postpartum depression may have a far-reaching impact not only on women who suffer from the condition but also on the direction of Sage itself. The Cambridge, MA-based drug developer said this morning that its therapy succeeded in ending depression in women during a … Continue reading “With Positive Postpartum Results, Sage Ponders More Mood Disorders”
Boston Tech Watch: Bain, New Google Project, Desktop Metal & More
In recent Boston tech news, Bain Capital Ventures reloaded its coffers for early-stage tech investments. Android co-founder Rich Miner is working on a new project at Google. Several startups scooped up more cash, including 3D printing firm Desktop Metal. And a healthtech company changed hands. Read on for details. —Bain Capital Ventures closed on a … Continue reading “Boston Tech Watch: Bain, New Google Project, Desktop Metal & More”
Dockwa Secures $2,000,000 Seed Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=474f9c13-227a-4716-b7d1-786b39a8c8d0 Date 7/12/2016 Company Name Dockwa Mailing Address 1 Commercial Wharf Newport, RI 02840 USA Company Description Dockwa takes the stress out of marina reservations. Download and tie-up. Website http://www.dockwa.com Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Seed Proceeds Purposes This summer, Dockwa has also expanded to the Midwest, one … Continue reading “Dockwa Secures $2,000,000 Seed Financing Round”
The Gap Has Two Sides
About two years ago, I was asked to join a Babson College panel discussing the gender gap in venture capital. At the center of the conversation would be the results from the Diana Project, a research study that examined our industry and the stark lack of representation of women investors and funded entrepreneurs. I accepted … Continue reading “The Gap Has Two Sides”
Promethean Founder Returns From India With Lessons For Entrepreneurs
When Promethean Power Systems’ founders wrote the original business plan for their cleantech startup at MIT, they intended to sell their products in India first. But none of them had ever set foot on Indian soil. After winning $10,000 as the runner-up in the MIT $100K pitch competition in 2007, co-founders Sorin Grama and Sam … Continue reading “Promethean Founder Returns From India With Lessons For Entrepreneurs”
An Homage to Larry Bock, Who Had God’s Hand on His Shoulder
When I told Larry Bock in an e-mail about four months ago that I had been diagnosed with cancer, the renowned San Diego life sciences investor asked if he might see me at UC San Diego’s Moores Cancer Center. “Maybe we can share an infusion room,” he replied. “I will be sending good thoughts your … Continue reading “An Homage to Larry Bock, Who Had God’s Hand on His Shoulder”
Dallas Police Shooting Highlights Role of Robots in Law Enforcement
Dallas—Robots have become a regular feature of combat, used by soldiers in Afghanistan and Iraq. But Dallas police’s use of such a device early Friday morning may be the first time law enforcement has deployed a robot to detonate a bomb to kill a suspect. Dallas Police Chief David Brown said police had tried to … Continue reading “Dallas Police Shooting Highlights Role of Robots in Law Enforcement”
Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data
With its stock price soaring following the release of strong data for its experimental ovarian cancer treatment, Tesaro completed a stock sale that net the company $409 million. Tesaro (NASDAQ: [[ticker:TSRO]]) said it sold 5.3 million shares of common stock at $81 per share. The Waltham, MA-based company’s stock was trading at $91.36 per share … Continue reading “Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data”
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche
Eleven Biotherapeutics says it’s in line for $22.5 million from partner Roche after an experimental eye treatment that the companies have partnered on hit a key early milestone that puts it on the path to starting clinical trials. In June, Eleven (NASDAQ: [[ticker:EBIO]]) licensed EBI-031, a drug it’s been developing for eye diseases like diabetic macular … Continue reading “Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche”
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More
This week started with celebrations of America’s birthday, and it has been dominated—biotech-wise—by America’s government. The Obama administration continued its high-profile involvement in the life sciences by updating its Precision Medicine Initiative, easing limits on doctors who want to fight opioid addiction, and stopping a clinical trial in one of the hottest biomedical fields, cancer … Continue reading “Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More”
Lantos Technologies Lands $3,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4281e752-5693-4c0a-b3a8-0c7efee6d88f Date 7/8/2016 Company Name Lantos Technologies Mailing Address 201 Edgewater Drive Wakefield, MA 01880 USA Company Description Lantos Technologies is working to commercialize a 3D digital scanner capable of measuring ear canal shape and tissue compliance. This method will eliminate the uncertainties associated with manual fits, greatly improving the performance of … Continue reading “Lantos Technologies Lands $3,000,000 New Funding Round”
ZIOPHARM Oncology Garners $120,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f757c429-1905-4439-8567-2ad314b434f7 Date 7/8/2016 Company Name ZIOPHARM Oncology Mailing Address 1 First Ave. Boston, MA 02129 USA Company Description Operations were initiated in January 2004 with the strategy of in-licensing proprietary drug candidate families with prior related-molecule efficacy in human cancer that would be efficiently and effectively developed and commercialized by a very … Continue reading “ZIOPHARM Oncology Garners $120,000,000 New Financing”
After Quickly Raising $11M, BevSpot Aims For Smart, Rapid Growth
Somebody forgot to tell BevSpot it’s supposed to be getting hard to raise venture capital right now. The Boston-based startup, which makes software for bars and restaurants, just nabbed $11 million in a Series B round led by previous backer Bain Capital Ventures. The deal came together quickly—about six weeks from the first conversation to … Continue reading “After Quickly Raising $11M, BevSpot Aims For Smart, Rapid Growth”